Biomarkers to noninvasively determine the atrial fibrillation progression phenotype: A bridge to individualized ablative therapy?

Elsevier, Heart Rhythm, 8(15), p. 1138-1139

Journal article published in 2018 by Roeliene Starreveld

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by